Baidu
map

临床上常遇到的27种过敏反应以及处理对策汇总!

2017-02-12 佚名 中国医学博士联络站

临床用药中经常发现过敏反应,甚至同一种药患者前几次无过敏反应,之后竟然出现了过敏反应。

临床用药中经常发现过敏反应,甚至同一种药患者前几次无过敏反应,之后竟然出现了过敏反应。



有些人的过敏反应主要是对药品里的杂质、辅料、添加剂过敏。不同厂家采用不同的生产工艺或生产设备,不同的辅料、添加剂,产品的杂质情况不同,也会出现“原来不过敏、后来过敏”的情况。此外,个人的免疫系统也会发生变化。 下面这些是临床中常见的过敏反应,要记住了!

1.复方丹参注射液 :

症状:头晕恶心呕吐、 皮疹

处理:换药处理

2.头孢类:

症状:皮疹

处理:5%葡萄糖酸钙20ml 地塞米松5mg扑尔敏2粒口服 5%gs100mlvc 2.0

3.磷霉素钠 :

症状:心慌、 脸色苍白、 头晕 、说不出话

处理:地塞米松5mg 静注5%gs 100ml 654-2 10mg

4.参麦注射液:

症状:输液反应 ,高烧40 度、口吐白沫、 昏迷不醒

处理:复方氨基比林4ml肌注 、5%gs100ml 、地塞米松10mg

5.克林霉素反应:

症状: 腹痛

处理:地塞米松5mg 静注 5%gs100 ml 654-2 10mg 不痛即停挂 ,口服奥美拉唑2粒 、胃炎干糖浆2包

6.复方氨基酸注射液:

症状:挂上5秒即休克

处理:肾上腺素1支肌注, 后来考虑该病人应该是晕针

7.复方氨基酸注射液:

症状:挂了大约100ml左右 ,恶心 、呕吐胸闷

处理:赶紧换药换管 5%gs250ml 、地塞米松5mg

8.雷尼替丁口服过敏 :

处理:停药,对症治疗

9.西咪替丁注射液:

症状:恶心、 呕吐 、头晕 、心慌

处理:停药口服

10.奥美拉唑口服:

症状:服下10分钟, 胸闷 、大汗淋漓 、恶心 、头晕

处理:无最佳治疗办法时只有瞩多喝水 ,根据情况去医院,患者自诉大概有1个小时缓解了症状。

11.阿米卡星+利巴韦林:

症状:不知道是输液反应还是药物问题 一天里出了2个输液反应的挂的都是阿米卡星3支和利巴韦林8支一个瓶里 ,发冷发抖

处理:赶紧换药换水, 肌注盐酸异丙嗪25mg 5%gs100ml 地塞米松10mg 口服尼美舒利1包 ,过了大约有半小时缓解

12.葡萄糖酸钙注射液:

症状:挂了大约有5秒钟, 病人说心慌 、恶心、 难受

处理:赶紧换药换空糖水水, 大约有个3分钟正常

13.vc注射液 :

症状:挂了大约2分钟。 病人说恶心、难受 、呕吐

处理:换药换空糖水 稍后没有事情

14.地塞米松注射液 :

症状:挂水 ,挂入大约有100ml左右, 脸红、心慌、 意识模糊(后来清醒后诉说我们的一举一动他都知道就是说不出话睁不开眼睛 )

处理:赶紧换空糖水, 扎针虎口 ,扎醒以后继续挂空糖水至正常

15.双黄连:

那些就不用讲了经常的事情 ,所以就基本不用了,皮疹 、喉头水肿 ,处理就是葡萄糖酸钙、 地塞米松 、扑尔敏

16.鱼腥草注射液:

现在已经不用了,遇见过反应,过敏性休克的肾上腺素1支、 葡萄糖酸钙20mg 地塞米松5mg

17.消炎痛

症状:呼吸困难

处理: 停药多喝水

18.替硝唑注射液:

症状:挂到三分之一的时候心慌、恶心 、胃痛

处理:换药就好转

19.左氧氟沙星注射液:

症状:挂上药就恶心、呕吐、 心慌 、难受

处理:立刻换药换管 ,一会就好转

20.利福霉素钠:

症状:挂了约3分钟 ,出现流鼻血, 发现2例 ,里面未加其他药

21.阿奇霉素 :

症状:挂了大约有10分钟, 咳嗽起来 、越来越咳 、诉呼吸困难 、喉咙痛

处理:赶紧换药换水 ,地塞米松5mg静注过了大约1个小时咳嗽缓解

22.扑感敏起皮疹

23.黄连素:

症状:恶心、呕吐、头晕

24.一个糖水反应:

症状:挂了后头晕 (没有糖尿病

25.阿昔洛韦粉针 :

症状:输入第2天后下肢不能着地

26.利巴韦林 注射液:

症状:脸色惨白、 全身无力 、过后诉腹痛、接着马上就休克

处理:赶紧打了1只肾上腺素、 1只扑尔敏加地塞米松一支,过后1分钟清醒过来 ,观察30分钟正常后回家

27.黄连素片 :

症状:口服后20分钟, 心慌恶心、 头昏 、

处理:不知道怎么解救, 只能嘱咐多喝水, 最后也好转

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1336621, encodeId=b5781336621b5, content=<a href='/topic/show?id=543794035c9' target=_blank style='color:#2F92EE;'>#过敏反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94035, encryptionId=543794035c9, topicName=过敏反应)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKeia4TJeMGvEH3wKKIBNjuHuIic1HDNOB10j4tCd3nbylxkxm6HSMfEaKkSu6OZOak4uZv7UVicsWEg/132, createdBy=bc9a2500116, createdName=zywlvao, createdTime=Tue Feb 14 09:57:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175857, encodeId=e05f1e585776, content=收益匪浅,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75db1652672, createdName=1ddcf060m56(暂无匿称), createdTime=Mon Feb 13 07:35:19 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175852, encodeId=909b1e5852e4, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58562C7F3188D3554.jpg, createdBy=67f21996849, createdName=萧寒, createdTime=Mon Feb 13 07:24:22 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175804, encodeId=cfea1e5804cc, content=这个真的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee471989203, createdName=墨尔, createdTime=Sun Feb 12 22:07:11 CST 2017, time=2017-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175794, encodeId=73bb1e57942f, content=很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVkILniabnuT4anP3RF0Vej3wtdQkUBaoVQQnEtgRJuCA6d08SVmHylJsibr3ZOX3icakISxC61l5Aw/132, createdBy=bd3e1976218, createdName=aleale, createdTime=Sun Feb 12 20:49:56 CST 2017, time=2017-02-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1336621, encodeId=b5781336621b5, content=<a href='/topic/show?id=543794035c9' target=_blank style='color:#2F92EE;'>#过敏反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94035, encryptionId=543794035c9, topicName=过敏反应)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKeia4TJeMGvEH3wKKIBNjuHuIic1HDNOB10j4tCd3nbylxkxm6HSMfEaKkSu6OZOak4uZv7UVicsWEg/132, createdBy=bc9a2500116, createdName=zywlvao, createdTime=Tue Feb 14 09:57:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175857, encodeId=e05f1e585776, content=收益匪浅,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75db1652672, createdName=1ddcf060m56(暂无匿称), createdTime=Mon Feb 13 07:35:19 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175852, encodeId=909b1e5852e4, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58562C7F3188D3554.jpg, createdBy=67f21996849, createdName=萧寒, createdTime=Mon Feb 13 07:24:22 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175804, encodeId=cfea1e5804cc, content=这个真的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee471989203, createdName=墨尔, createdTime=Sun Feb 12 22:07:11 CST 2017, time=2017-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175794, encodeId=73bb1e57942f, content=很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVkILniabnuT4anP3RF0Vej3wtdQkUBaoVQQnEtgRJuCA6d08SVmHylJsibr3ZOX3icakISxC61l5Aw/132, createdBy=bd3e1976218, createdName=aleale, createdTime=Sun Feb 12 20:49:56 CST 2017, time=2017-02-12, status=1, ipAttribution=)]
    2017-02-13 1ddcf060m56(暂无匿称)

    收益匪浅,有用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1336621, encodeId=b5781336621b5, content=<a href='/topic/show?id=543794035c9' target=_blank style='color:#2F92EE;'>#过敏反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94035, encryptionId=543794035c9, topicName=过敏反应)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKeia4TJeMGvEH3wKKIBNjuHuIic1HDNOB10j4tCd3nbylxkxm6HSMfEaKkSu6OZOak4uZv7UVicsWEg/132, createdBy=bc9a2500116, createdName=zywlvao, createdTime=Tue Feb 14 09:57:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175857, encodeId=e05f1e585776, content=收益匪浅,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75db1652672, createdName=1ddcf060m56(暂无匿称), createdTime=Mon Feb 13 07:35:19 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175852, encodeId=909b1e5852e4, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58562C7F3188D3554.jpg, createdBy=67f21996849, createdName=萧寒, createdTime=Mon Feb 13 07:24:22 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175804, encodeId=cfea1e5804cc, content=这个真的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee471989203, createdName=墨尔, createdTime=Sun Feb 12 22:07:11 CST 2017, time=2017-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175794, encodeId=73bb1e57942f, content=很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVkILniabnuT4anP3RF0Vej3wtdQkUBaoVQQnEtgRJuCA6d08SVmHylJsibr3ZOX3icakISxC61l5Aw/132, createdBy=bd3e1976218, createdName=aleale, createdTime=Sun Feb 12 20:49:56 CST 2017, time=2017-02-12, status=1, ipAttribution=)]
    2017-02-13 萧寒

    受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1336621, encodeId=b5781336621b5, content=<a href='/topic/show?id=543794035c9' target=_blank style='color:#2F92EE;'>#过敏反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94035, encryptionId=543794035c9, topicName=过敏反应)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKeia4TJeMGvEH3wKKIBNjuHuIic1HDNOB10j4tCd3nbylxkxm6HSMfEaKkSu6OZOak4uZv7UVicsWEg/132, createdBy=bc9a2500116, createdName=zywlvao, createdTime=Tue Feb 14 09:57:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175857, encodeId=e05f1e585776, content=收益匪浅,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75db1652672, createdName=1ddcf060m56(暂无匿称), createdTime=Mon Feb 13 07:35:19 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175852, encodeId=909b1e5852e4, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58562C7F3188D3554.jpg, createdBy=67f21996849, createdName=萧寒, createdTime=Mon Feb 13 07:24:22 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175804, encodeId=cfea1e5804cc, content=这个真的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee471989203, createdName=墨尔, createdTime=Sun Feb 12 22:07:11 CST 2017, time=2017-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175794, encodeId=73bb1e57942f, content=很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVkILniabnuT4anP3RF0Vej3wtdQkUBaoVQQnEtgRJuCA6d08SVmHylJsibr3ZOX3icakISxC61l5Aw/132, createdBy=bd3e1976218, createdName=aleale, createdTime=Sun Feb 12 20:49:56 CST 2017, time=2017-02-12, status=1, ipAttribution=)]
    2017-02-12 墨尔

    这个真的很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1336621, encodeId=b5781336621b5, content=<a href='/topic/show?id=543794035c9' target=_blank style='color:#2F92EE;'>#过敏反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94035, encryptionId=543794035c9, topicName=过敏反应)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKeia4TJeMGvEH3wKKIBNjuHuIic1HDNOB10j4tCd3nbylxkxm6HSMfEaKkSu6OZOak4uZv7UVicsWEg/132, createdBy=bc9a2500116, createdName=zywlvao, createdTime=Tue Feb 14 09:57:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175857, encodeId=e05f1e585776, content=收益匪浅,有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75db1652672, createdName=1ddcf060m56(暂无匿称), createdTime=Mon Feb 13 07:35:19 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175852, encodeId=909b1e5852e4, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161218/IMG58562C7F3188D3554.jpg, createdBy=67f21996849, createdName=萧寒, createdTime=Mon Feb 13 07:24:22 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175804, encodeId=cfea1e5804cc, content=这个真的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee471989203, createdName=墨尔, createdTime=Sun Feb 12 22:07:11 CST 2017, time=2017-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=175794, encodeId=73bb1e57942f, content=很全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVkILniabnuT4anP3RF0Vej3wtdQkUBaoVQQnEtgRJuCA6d08SVmHylJsibr3ZOX3icakISxC61l5Aw/132, createdBy=bd3e1976218, createdName=aleale, createdTime=Sun Feb 12 20:49:56 CST 2017, time=2017-02-12, status=1, ipAttribution=)]
    2017-02-12 aleale

    很全面

    0

相关资讯

原来,过敏是能要命的

“致命”的过敏曾有一篇名为《北大医院医生手记|医生药物过敏惊险自救》的文章在朋友圈疯传,一名医生凭借自己的专业知识,当然也加上一点运气,成功的从“过敏性休克”自救,捡回了一条命。这件事,也给广大群众提了个醒:原来,过敏是能要命的!直到现在,仍有很多人误以为过敏没什么大不了,不过是长皮疹,殊不知某些过敏可能导致过敏性休克,甚至会快速致命。过敏的致命原因,大部分是身体对过敏物质瞬间产生过激反应,导致喉

注意!CFDA又要求这些药修订说明书了

导语:近日,食药监总局发布几条公告,决定对感冒清片、穿王消炎制剂、肾衰宁制剂等几样药品说明书【不良反应】、【禁忌】和【注意事项】项进行修订。

Lancet:全身超过90%的皮肤都存在红棕色皮损,且持续时间超过30年,啥病?——案例报道

患者男,63岁,于2016年1月就诊;长达32年的红棕色皮肤病变在前一年出现恶化,且伴每天腹痛、瘙痒、潮红、关节疼痛和疲劳。 查体如上图所示,超过90%的皮肤都存在红棕色皮肤病变,只有手掌、脚底和头部幸免于此。 辅助检查:血清类胰蛋白酶70·5μg/L,正常值上限的六倍! 皮肤活检:多个肥大细胞。 结合患者临床表现、血清类胰蛋白酶升高和病理结果,患者诊断为:肥大细胞增多

准妈妈孕期过敏或增加其后代多动症及自闭症的发生风险

一项关于大鼠的新研究解释了为什么怀孕期间过敏会导致儿童注意力不集中多动症和自闭症风险增高。俄亥俄州立大学的研究者发现孕期过敏会导致胎鼠和新生大鼠脑组成显著改变。俄亥俄州立大学心理学助理教授Kathryn Lenz领导的研究团队发现,出生前过敏原暴露的动物生长到成年期出现多动和反社会行为并焦虑减少。尽管过敏和注意缺陷多动障及自闭症之间建立了联系,同样炎症和患自闭症的风险,精神分裂症和注意缺陷多动障也

盘点:了解“季节”对健康的影响,你也能做半个大仙!

不仅是昼夜节律,四季变换对我们的健康也会有影响! 【1】出生季节影响Addison病 研究人员对英格兰和威尔士在1963-1972年间出生的(n =8180180)例参与者进行了分析,其中415例为Addison病患者(167例为女性)。此外,研究人员对231例波兰Addison病成年患者与1980、1990、2010和2012年的总出生人口(n=2421384)进行了相似的对比。

盘点:几项关于“吃花生预防花生过敏”的研究汇总

越来越多的人对花生过敏,越来越多的研究表明,在孩子小的时候让其接触花生能够为孩子提供长久的保护,避免对花生产生过敏。 【1】预防花生过敏要从娃娃抓起 LEAP的临床研究主要结果已经在2015年得到发表,研究表明,将花生制品加入到花生过敏高风险婴儿的饮食当中,能够降低儿童在生长过程中对花生制品过敏的风险,并且相比于完全不接触花生制品的儿童来说,风险可降低81%。而这项最新研究的目的在于进一步

Baidu
map
Baidu
map
Baidu
map